Entelos Holding Corp. (“Entelos” or the “Company”), a premiere provider of in silico modeling and simulation products and services that help pharmaceutical and consumer product companies make informed decisions in their product development process, today announced that Mark Hovde has joined the senior management team of the Company as Vice President of Sales and Marketing and Will Frederick has joined the senior management team as Chief Financial Officer, effective immediately.

“Mark and Will both bring to Entelos a track record of successful leadership developing and executing winning business models in our market space,” said Shawn O’Connor, President and Chief Executive Officer of Entelos. “Their contributions will be invaluable to our future growth through the development of new products and services and continued delivery of superior service to our customers.”

Mr. Hovde has more than 20 years of experience in sales and marketing for organizations providing innovative services, software and data to the pharmaceutical, biotechnology and chemical industries. Prior to joining Entelos, Mr. Hovde was Senior Vice President of Business Development for Certara. Previously, Mr. Hovde was the co-founder of DataEdge, LLC, a developer of novel informatics that help reduce the time and cost of clinical trials.

Mr. Frederick has more than 20 years of experience in global finance, accounting and administrative management in senior financial positions for a range of private and publicly held companies varying from start-up to Fortune 500 businesses in multiple industries. Prior to joining Entelos, Mr. Frederick was CFO of the Products Division of Avaya, a $5B global provider of business collaboration solutions. Previously, Mr. Frederick was CFO at Pharsight, a publicly owned provider of software, consulting, and regulatory services for optimizing clinical drug development.

Entelos is an in silico modeling and simulation software and services company delivering predictive technologies reducing risk, time, and cost of product development for pharmaceutical, biotechnology, nutrition and consumer products customers. The Company's PhysioLab® systems biology platforms generate virtual patient populations providing highly predictive analyses to develop safer and more effective drugs, foods and consumer products. Entelos’ understanding of patient variability has significant application to the emerging field of personalized medicine. The Company is headquartered in San Mateo, California. For more information, please visit www.entelos.com.